- Summary
- Price Reports
- Price History
- Add To Your Stocklist
- View your Stocklist
- Basic Chart
- Interactive Chart
- Headlines
- Company Snapshot
- Summary Reports
- Free Annual Report
- Estimate Snapshot
- Estimate Report
- Mobile Quote
- Real-Time Quote
- Streaming Quote
|
Caraco Pharmaceutical Labs | Company Snapshot
-
![]()
-
-
-
Vol:
-
Last Trade:
|
CARACO PHARMACEUTICAL LABS
CARACO PHARMACEUTICAL is engaged in the business of developing, manufacturing and marketing generic drugs for the ethical (prescription) and over-the-counter(non-prescription) markets. A generic drug is a pharmaceutical product which is the chemical and therapeutic equivalent of a brand-name drug as to which the patent and/or market exclusivity has expired. Generics are well accepted for substitution of brand products as they sell at a discount to the branded product's price and for their equivalence in quality and bioavailability.
|
|
| Symbol: |
CPD |
| Exchange(s): |
American Stock Exchange |
| Industry: |
Consumer Products (Biotechnology & Pharmaceuticals) |
| 5-Star Rating: |
 |
|
ANNUAL FINANCIALS
|
|
|
Mar 31, 2009
12 Months
us$
|
Mar 31, 2008
12 Months
us$
|
Mar 31, 2007
12 Months
us$
|
3Yr.
Growth
% Change
|
|
Total Revenue ($000)
|
337,170
|
350,360
|
117,020
|
59.70
|
|
Earnings before Interest & Tax ($000)
|
29,470
|
42,390
|
26,870
|
N/A
|
|
Profit/Loss ($000)
|
20,530
|
35,380
|
26,850
|
N/A
|
|
Earnings per Share
|
0.60
|
1.19
|
1.02
|
N/A
|
|
Total Assets ($000)
|
236,480
|
538,270
|
114,460
|
45.21
|
|
Dividends Per Share
|
0.00
|
0.00
|
0.00
|
|
|
Return on Com. Equity
|
18.23
|
66.42
|
1,031.74
|
|
|
Employees
|
N/A
|
N/A
|
N/A
|
|
|
|
|
|
Trailing 12 Month Results
|
|
|
12 Months ended
Dec 31, 2009,us$
|
12 Months ended
Dec 31, 2008,us$
|
%Change
|
|
Total Revenue ($000)
|
229,430
|
477,940
|
-52.00
|
|
Profit/Loss ($000)
|
-8,190
|
34,430
|
-123.79
|
|
Earnings per Share
|
-0.24
|
1.06
|
-122.64
|
|
Dividends Per Share
|
0.00
|
0.00
|
|
Number of Shares
|
39,090,000
|
34,740,000
|
|
|
|
|
|
COMPANY INFORMATION
|
| Key Personnel |
| CEO: Dilip S. Shanghvi, Chmn. |
| CFO: Mukul Rathi, Interim C.F.O.; Princ. Acctg. |
| |
| Contact Information |
| Address: |
1150 Elijah McCoy Drive,
Detroit,
MI,
60134 |
Phone: |
313-871-8400 |
| Fax: |
313-871-8314 |
| Web Address: |
www.caraco.com |
| E-Mail : |
amiles@caraco.com |
| |
| Incorporation:
| United States |
| |
|
Securities:
|
CPD-A
|
|
| |
|
|
| |
|
|
Financial data is provided by Zacks Investment Research.
| |
All information on this site is compiled by CTVglobemedia Publishing Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, CTVglobemedia Publishing Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.
Copyright © 2010 CTVglobemedia Publishing Inc. All rights reserved.
|
|
|
